ATELLICA IM ANTI-HBE2 QUALITY CONTROL (AHBE2 QC) - INVIMA Registration 62746c1589dc94372c5ad0c4d26113e0
Access comprehensive regulatory information for ATELLICA IM ANTI-HBE2 QUALITY CONTROL (AHBE2 QC) (ATELLICA IM ANTI-HBE2 QUALITY CONTROL (AHBE2 QC)) in the Colombia medical device market through Pure Global AI's free database. This III medical device is registered under INVIMA analysis ID 62746c1589dc94372c5ad0c4d26113e0 and manufactured by SIEMENS HEALTHCARE S.A.S.
This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.
EL CONTROL DE CALIDAD DE ANTI-HBE2 (CC DE AHBE2) ATELLICA® IM ESTÁ DESTINADO AL USO DE _x000D_ DIAGNÓSTICO IN VITRO EN LA SUPERVISIÓN DEL RENDIMIENTO DEL ENSAYO ANTI-HBE2 (AHBE2) _x000D_ ATELLICA IM CON EL ANALIZADOR ATELLICA® IM.
THE QUALITY CONTROL OF ANTI-HBE2 (AHBE2 DC) ATELLICA® IM IS INTENDED FOR THE USE OF _x000D_ IN VITRO DIAGNOSTICS IN THE PERFORMANCE MONITORING OF THE ANTI-HBE2 (AHBE2) ASSAY _x000D_ ATELLICA IM WITH THE ATELLICA® IM ANALYZER.